STADA Arzneimittel AG — Director's Dealing 2014

Oct 20, 2014

News Details

Directors’ Dealings | 20 October 2014 09:52

DGAP-DD: STADA Arzneimittel AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a service of EQS Group AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Last name: Retzlaff First name: Silvia Relationship to a person performing managerial responsibilities: Spouse or registered partner Details of the person performing managerial responsibilities Position: Member of a managing body Information about the transaction with duty of notification Description of the financial instrument: Share ISIN/WKN of the financial instrument: DE0007251803 Type of transaction: Buy Date: 17.10.2014 Price: 16.45 Currency: EUR No. of items: 400 Total amount traded: 6580.00 Place: Xetra Explanation for publication: Exercise of Option Information about the company with duty of publication Issuer: STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Deutschland ISIN: DE0007251803 WKN: 725180 End of Directors’ Dealings Notification (c) DGAP 20.10.2014 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 19701